搜索临床试验以:聚乙二醇化重组人精氨酸酶 I
总计1376个结果
-
Bio-Cancer Treatment International LimitedThe University of Hong Kong; Chinese University of Hong Kong完全的
-
Bio-Cancer Treatment International LimitedOncotherapeutics完全的
-
Bio-Cancer Treatment International LimitedThe University of Hong Kong; Chinese University of Hong Kong完全的
-
Eisai Inc.Halozyme Therapeutics终止
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)撤销
-
Bio-Cancer Treatment International LimitedThe University of Hong Kong; Chinese University of Hong Kong完全的
-
Shandong UniversityShandong Provincial Hospital; The First Affiliated Hospital of Dalian Medical University完全的
-
Bio-Cancer Treatment International LimitedThe University of Hong Kong终止
-
Maxygen Holdings Ltd.Parexel; Maxygen ApS; Maxygen, Inc.未知
-
Halozyme Therapeutics完全的
-
Peking Union Medical CollegeShenyang Sunshine Pharmaceutical Co., LTD.未知
-
Ludwig Institute for Cancer ResearchMemorial Sloan Kettering Cancer Center; National Taiwan University Hospital; Duke University; Chang... 和其他合作者终止
-
Sun Yat-sen University招聘中
-
University of MilanEli Lilly and Company未知
-
Shandong UniversityThe First Affiliated Hospital of Anhui Medical University; The Affiliated Hospital of the Chinese... 和其他合作者完全的
-
Nanfang Hospital of Southern Medical UniversityFirst Affiliated Hospital, Sun Yat-Sen University; Guangdong Provincial People's Hospital; Third... 和其他合作者未知
-
Halozyme TherapeuticsBaxter Healthcare Corporation完全的
-
Halozyme Therapeutics终止
-
Novo Nordisk A/S完全的健康 | 先天性出血性疾病 | 带有抑制剂的血友病 A | 带有抑制剂的血友病 B | 获得性出血性疾病 | 获得性血友病 | 先天性 FVII 缺陷 | 格兰兹曼病法国
-
Novo Nordisk A/S完全的
-
Novo Nordisk A/S完全的